The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland

被引:7
|
作者
Bochenek, Tomasz [1 ]
Kocot, Ewa [2 ]
Rodzinka, Marcin [3 ]
Godman, Brian [4 ,5 ]
Maciejewska, Katarzyna [3 ]
Kamal, Susan [6 ]
Pilc, Andrzej [7 ]
机构
[1] Jagiellonian Univ, Dept Drug Management, Fac Hlth Sci, Coll Med, PL-31531 Krakow, Poland
[2] Jagiellonian Univ, Hlth Econ & Social Secur Dept, Fac Hlth Sci, Coll Med, Krakow, Poland
[3] Jagiellonian Univ, Hlth Promot Dept, Fac Hlth Sci, Coll Med, Krakow, Poland
[4] Karolinska Inst, Div Clin Pharmacol, Stockholm, Sweden
[5] Strathclyde Univ, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland
[6] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Community Pharm Dept, Geneva, Switzerland
[7] Polish Acad Sci, Inst Pharmacol, Dept Neurobiol, Krakow, Poland
关键词
Health technology assessment; HTA; pharmaceutical reimbursement; public information; citizens' rights; transparency; Poland; RISK-SHARING ARRANGEMENTS; INVOLVEMENT; MEDICINES;
D O I
10.1080/14737167.2017.1262767
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The appropriate access to public information is very important for healthcare system stakeholders. The goal of this study was to examine how the execution of the formally existing right to public information on the HTA-based recommendations on reimbursement of new health technologies from public funds has been changing in Poland.Methods: All recommendations published within two predefined equal periods of time between 2013 and 2015 were analyzed. The gathered data was subjected to statistical analysis.Results: The frequency and intensity of censoring the published HTA-based recommendations on the pharmaceutical reimbursement has diminished. The text readability and clarity of message has improved, although the degree of decisiveness of the recommendations has dropped.Conclusion: The positive changes in the public communication policy should be continued. The transparency of the HTA-based recommendations should be increased further in some areas in the future.
引用
收藏
页码:385 / 400
页数:16
相关论文
共 50 条
  • [1] THE TRANSPARENCY OF PUBLISHED RECOMMENDATIONS ON REIMBURSEMENT OF HEALTH TECHNOLOGIES IN POLAND
    Bochenek, T.
    Kocot, E.
    Rodzinka, M.
    Godman, B.
    Maciejewska, K.
    Kamal, S.
    Pilc, A.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A447 - A448
  • [2] Reimbursement of biosimilars in Poland: is there a link to health technology assessment?
    Neumann, Dominika
    Jablecka, Anna
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 781 - 792
  • [3] IMPLEMENTING HEALTH TECHNOLOGY ASSESSMENT-BASED RECOMMENDATIONS IN FINLAND: MANAGED UPTAKE OF MEDICAL METHODS
    Sihvo, Sinikka
    Ikonen, Tuija
    Makela, Marjukka
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2017, 33 (04) : 430 - 433
  • [4] Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012-2014, a retrospective analysis
    Kawalec, Pawel
    Malinowski, Krzysztof Piotr
    [J]. HEALTH POLICY, 2016, 120 (11) : 1240 - 1248
  • [5] Health technology assessment and its impact on pharmaceutical pricing and reimbursement policies
    Castillo-Labordo, Carla
    Silva-Illanes, Nicolas
    [J]. REVISTA MEDICA DE CHILE, 2014, 142 (01) : S33 - S38
  • [6] Recommendations for Publishing Assessment-Based Articles in JCEHP
    Wood, Timothy J.
    [J]. JOURNAL OF CONTINUING EDUCATION IN THE HEALTH PROFESSIONS, 2018, 38 (03) : 154 - 157
  • [7] The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries
    Oortwijn, Wija
    Mathijssen, Judith
    Banta, David
    [J]. HEALTH POLICY, 2010, 95 (2-3) : 174 - 184
  • [8] THE INFLUENCE OF RECOMMENDATIONS RELATED TO CARDIOVASCULAR DRUGS ISSUED BY AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AOTM) IN YEARS 2005-2012 FOR THE REIMBURSEMENT DECISIONS
    Ofierska-Sujkowska, G.
    Jagodzinska-Kalinowska, K.
    Matusewicz, W.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A296 - A297
  • [9] PHARMACEUTICAL SYSTEM IN UKRAINE: IMPLEMENTATION OF EXTERNAL REFERENCE PRICING, REIMBURSEMENT PROGRAMS AND HEALTH TECHNOLOGY ASSESSMENT
    Piniazhko, O.
    Zaliska, O.
    Ilyk, R.
    Stasiv, Kh-O
    [J]. PHARMACIA, 2018, 65 (02) : 28 - 39
  • [10] Assessment-based health informatics curriculum improvement
    Berner, Eta S.
    Dorsey, Amanda D.
    Garrie, Robert L.
    Qu, Haiyan
    [J]. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2016, 23 (04) : 813 - 818